OEC reports strong Q3 earnings

Article

Mobile C-arm manufacturer OEC Medical Systems of Salt Lake Cityreported healthy earnings for its third quarter (end-September),despite a slight drop in revenues for the period. The companyattributed the results to successful efforts to control costs.

Mobile C-arm manufacturer OEC Medical Systems of Salt Lake Cityreported healthy earnings for its third quarter (end-September),despite a slight drop in revenues for the period. The companyattributed the results to successful efforts to control costs.

For the quarter, OEC reported net income of $3.1 million onrevenues of $25.5 million. Net income rose 7% compared to the$2.9 million profit reported in the same period last year, whilerevenues dropped 7% compared to the $27.3 million in sales postedin last year's quarter.

OEC's year-to-date results are higher both in revenues andincome. The company has posted sales of $74.4 million in the firstnine months of 1995, compared to $69.9 million in the same periodlast year. Net income so far stands at $8.4 million compared to$5.6 million year-to-date in 1994.

OEC chairman, president and CEO Ruediger Naumann-Etienne saidsales in the most recent quarter were lower because of strongerthan expected revenue in last year's third quarter. That quarterbenefited from pent-up demand for OEC's flagship Series 9600 C-arm,which began shipping in the second quarter of 1994 after commercializationdelays.

Naumann said OEC has enjoyed particularly strong demand forits products in international markets, and OEC is on track todouble last year's global sales by year end. Its performance shouldimprove when two lower cost C-arms, Compact 7600 and Mini 6600,are introduced in coming months.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.